Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 1/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 3/20 | 0.32 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.32 |
| ▸ | HTR1A | P08908 | 2/20 | 0.32 |
| ▸ | HTR7 | P34969 | 2/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29366427 | 1.00 | PDCD1 (0.34) | PDCD1CD274ADRA2AADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL3822639 | 0.97 | ADRA2A (0.34) | PDCD1CD274ADRA2AADRA2BADRA2C | |
| Dimethylamine SCHEMBL1453283 | 0.95 | TDO2 (0.33) | PDCD1CD274ADRA2AADRA2BADRA2C | |
| SCHEMBL6056122 | 0.93 | PDCD1 (0.30) | PDCD1CD274 | |
| SCHEMBL16683341 | 0.93 | PDCD1 (0.30) | PDCD1CD274NTRK1NTRK3 | |
| SCHEMBL1452295 | 0.93 | PDCD1 (0.30) | PDCD1CD274 | |
| SCHEMBL7050759 | 0.92 | PDCD1 (0.35) | PDCD1CD274ADRA2AADRA2BADRA2C | |
| SCHEMBL1452790 | 0.92 | MAPK1 (0.39) | NPC1ALDH1A1RAB9ASMN1; SMN2HTR2B | |
| SCHEMBL5838399 | 0.91 | PDK2 (0.31) | PDK2PDK4NR1H4 | |
| SCHEMBL7053161 | 0.90 | PDCD1 (0.34) | PDCD1CD274ADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590174-B2 | Curable compositions comprising telechelic polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-03-31 | — | — | US | disclosed |
| EP-3902808-B1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3902810-B1 | CURABLE COMPOSITIONS COMPRISING TELECHELIC POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20250333549-A1 | Process for Preparing a Catalyst for Olefin Polymerization | HANWHA SOLUTIONS CORP (KR) | 2025-10-30 | — | — | US | disclosed |
| EP-3356374-B1 | MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-3875496-B1 | METHOD FOR PREPARING CATALYST FOR OLEFIN POLYMERIZATION | HANWHA SOLUTIONS CORP (KR) | 2025-09-03 | — | — | EP | disclosed |
| US-12384859-B2 | Process for preparing a catalyst for olefin polymerization | Hanwha Solutions Corporation (KR) | 2025-08-12 | — | — | US | disclosed |
| EP-3902807-B1 | ORGANOMETALLIC CHAIN TRANSFER AGENTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-12351707-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-08 | — | — | US | disclosed |
| US-12275810-B2 | Telechelic polyolefins and processes for preparing the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-04-15 | — | — | US | disclosed |
| US-5770753-A | ADDITION POLYMERIZATION CATALYST | TARGOR GMBH (DE) | 1998-06-23 | — | — | US | disclosed |
| EP-0692505-B1 | Process for procucing propylene block copolymers | MITSUBISHI CHEM CORP (JP) | 1998-01-28 | — | — | EP | disclosed |
| EP-0576970-B1 | Metallocenes with arylsubstituted indenyl-derivatives as ligands, process for their preparation and their use as catalysts | HOECHST AG (DE) | 1998-01-14 | — | — | EP | disclosed |
| EP-0790076-A2 | Catalysts containing metallocenes with arylsubstituted indenyl derivatives as ligands, process and intermediates for the preparation of these metallocenes and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-08-20 | — | — | EP | disclosed |
| EP-0776913-A2 | High molecular weight copolymers | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-06-04 | — | — | EP | disclosed |
| US-5623022-A | VAPOR PHASE; USING COORDINATION CATALYST | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-04-22 | — | — | US | disclosed |
| EP-0692505-A2 | Process for procucing propylene block copolymers | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-01-17 | — | — | EP | disclosed |
| US-5360921-A | REACTING LITHIUM, SODIUM OR POTASSIUM SALT OF A CYCLOPENTADIENE DERIVATIVE WITH A SILICON OR GERMANIUM HALIDE COMPOUND IN THE PRESENCE OF A CYANIDE OR A THIOCYANATE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-01 | — | — | US | disclosed |
| EP-0617044-A2 | Process for preparing cyclopentadienyl group-containing silicon compound or cyclopentadienyl group-containing germanium compound | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-28 | — | — | EP | disclosed |
| EP-0576970-A1 | Metallocenes with arylsubstituted indenyl-derivatives as ligands, process for their preparation and their use as catalysts | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590174-B2 | Curable compositions comprising telechelic polyolefins | CCT2, TCP1, ECH1 | PDCD1 1990/4885CD274 961/4885ADRA2A 2776/4885 |
| US-12351707-B2 | Curable compositions comprising unsaturated polyolefins | ACSL6, ELOVL6, ALOX5 | PDCD1 1205/4885CD274 1050/4885ADRA2A 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.